Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BARDA
Pharma
FDA OKs Basilea's antibiotic Zevtera for 3 types of infections
The FDA has approved Basilea Pharmaceutica’s antibiotic Zevtera (ceftobiprole) for three different kinds of infections.
Kevin Dunleavy
Apr 4, 2024 8:45am
Venatorx, Melinta's antibiotic rejected over manufacturing issues
Feb 23, 2024 10:55am
Gritstone's BARDA-funded COVID vaccine hit with delay
Feb 12, 2024 1:10pm
Emergent lines up BARDA pact to supply anthrax shot in the US
Nov 28, 2023 4:20pm
Government-backed manufacturer AktiVax shuts down, lays off 70
Sep 5, 2023 3:53pm
With US deal, BN helps restore supply of smallpox, mpox vaccine
Aug 3, 2023 12:53pm